Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
Endocrine Connections|November 8, 2018
Declining free thyroxine levels over time in irradiated childhood brain tumor survivorsLaura van Iersel, Sarah C Clement, Antoinette Y N Schouten-van Meeteren, et al.JCO Precision Oncology|November 25, 2021
Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid TumorsLieke M J van Zogchel, Nathalie S M Lak, Onno J H M Verhagen, et al.JAMA Ophthalmology|September 15, 2022
Ophthalmological Findings in Youths With a Newly Diagnosed Brain TumorMyrthe A Nuijts, Inge Stegeman, Tom van Seeters, et al.European Journal of Endocrinology|July 29, 2021
Prevalence and risk factors of hypothalamic-pituitary dysfunction in infant and toddler childhood brain tumor survivorsC A Lebbink, T P Ringers, A Y N Schouten-van Meeteren, et al.Cancers|March 13, 2025
A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer TherapyCarlien A M Bennebroek, Judith van Zwol, Maartje C Montauban van Swijndregt, et al.Oncotarget|July 3, 2018
MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomasAnika Bongaarts, Avanita S Prabowo, Andrea Arena, et al.Nature Medicine|June 15, 2023
A joint international consensus statement for measuring quality of survival for patients with childhood cancerRebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2021
High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary DysfunctionJiska van Schaik, Ichelle M A A van Roessel, Netteke A Y N Schouten-van Meeteren, et al.Neuro-Oncology|October 11, 2017
Pediatric low-grade gliomas: next biologically driven stepsDavid T W Jones, Mark W Kieran, Eric Bouffet, et al.Oncotarget|December 10, 2017
Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutationsAnika Bongaarts, Krinio Giannikou, Roy J Reinten, et al.Pageof 16